Advanced

Mid-term outcome of endovascular revascularization for chronic mesenteric ischaemia.

Dias, Nuno LU ; Acosta, Stefan LU ; Resch, Tim LU ; Sonesson, Björn LU ; Alhadad, Alaa LU ; Malina, Martin LU and Ivancev, Krassi LU (2010) In British Journal of Surgery 97. p.195-201
Abstract
BACKGROUND:: This study aimed to assess mid-term outcome after endovascular revascularization of chronic occlusive mesenteric ischaemia (CMI) and to identify possible predictors of mortality. METHODS:: Consecutive patients undergoing primary elective stenting for CMI between 1995 and 2007 were registered prospectively in a database. Patients with acute ischaemia were excluded. Retrospective case-note review and data analysis were performed. RESULTS:: Forty-three patients (10 men) were treated for stable (n = 30) or exacerbated (n = 13) CMI. Their median (interquartile range (i.q.r.)) age was 70 (60-79) years. Revascularization was successful in 47 of 49 vessels. The superior mesenteric artery (SMA), either alone (n = 34) or in combination... (More)
BACKGROUND:: This study aimed to assess mid-term outcome after endovascular revascularization of chronic occlusive mesenteric ischaemia (CMI) and to identify possible predictors of mortality. METHODS:: Consecutive patients undergoing primary elective stenting for CMI between 1995 and 2007 were registered prospectively in a database. Patients with acute ischaemia were excluded. Retrospective case-note review and data analysis were performed. RESULTS:: Forty-three patients (10 men) were treated for stable (n = 30) or exacerbated (n = 13) CMI. Their median (interquartile range (i.q.r.)) age was 70 (60-79) years. Revascularization was successful in 47 of 49 vessels. The superior mesenteric artery (SMA), either alone (n = 34) or in combination with the coeliac trunk (n = 6), was the predominant target vessel. No patient died within 30 days. Median follow-up was 43 (i.q.r. 25-63) months and the estimated (s.e.) 3-year overall survival rate was 76(7) per cent. Two patients died from distal SMA occlusive disease and intestinal infarction after 6 and 18 months respectively. Previous stroke (P = 0.016), male sex (P = 0.057) and age (P = 0.066) were associated with mid-term mortality on univariable, but not multivariable analysis. Reintervention was needed in 14 patients, achieving a 3-year cumulative rate of freedom from recurrent symptoms of 88(5) per cent. CONCLUSION:: Endovascular treatment provided high early and mid-term survival rates in this series of patients with CMI, with low complication rates. Copyright (c) 2009 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
British Journal of Surgery
volume
97
pages
195 - 201
publisher
John Wiley & Sons
external identifiers
  • wos:000274098100009
  • pmid:20035543
  • scopus:74549194474
ISSN
1365-2168
DOI
10.1002/bjs.6819
language
English
LU publication?
yes
id
5bc76c1f-695a-4136-83c9-73efd6f2eab5 (old id 1523284)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/20035543?dopt=Abstract
date added to LUP
2010-01-08 11:05:18
date last changed
2018-05-29 10:00:32
@article{5bc76c1f-695a-4136-83c9-73efd6f2eab5,
  abstract     = {BACKGROUND:: This study aimed to assess mid-term outcome after endovascular revascularization of chronic occlusive mesenteric ischaemia (CMI) and to identify possible predictors of mortality. METHODS:: Consecutive patients undergoing primary elective stenting for CMI between 1995 and 2007 were registered prospectively in a database. Patients with acute ischaemia were excluded. Retrospective case-note review and data analysis were performed. RESULTS:: Forty-three patients (10 men) were treated for stable (n = 30) or exacerbated (n = 13) CMI. Their median (interquartile range (i.q.r.)) age was 70 (60-79) years. Revascularization was successful in 47 of 49 vessels. The superior mesenteric artery (SMA), either alone (n = 34) or in combination with the coeliac trunk (n = 6), was the predominant target vessel. No patient died within 30 days. Median follow-up was 43 (i.q.r. 25-63) months and the estimated (s.e.) 3-year overall survival rate was 76(7) per cent. Two patients died from distal SMA occlusive disease and intestinal infarction after 6 and 18 months respectively. Previous stroke (P = 0.016), male sex (P = 0.057) and age (P = 0.066) were associated with mid-term mortality on univariable, but not multivariable analysis. Reintervention was needed in 14 patients, achieving a 3-year cumulative rate of freedom from recurrent symptoms of 88(5) per cent. CONCLUSION:: Endovascular treatment provided high early and mid-term survival rates in this series of patients with CMI, with low complication rates. Copyright (c) 2009 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.},
  author       = {Dias, Nuno and Acosta, Stefan and Resch, Tim and Sonesson, Björn and Alhadad, Alaa and Malina, Martin and Ivancev, Krassi},
  issn         = {1365-2168},
  language     = {eng},
  pages        = {195--201},
  publisher    = {John Wiley & Sons},
  series       = {British Journal of Surgery},
  title        = {Mid-term outcome of endovascular revascularization for chronic mesenteric ischaemia.},
  url          = {http://dx.doi.org/10.1002/bjs.6819},
  volume       = {97},
  year         = {2010},
}